Manuela Moreno-Ramírez has graduated the Faculty of Medicine, University of Cádiz, Spain. Soon afterwards she became nephrologist and get interesting in vascular access. Since 2020, she is working as nephrologist in AVERICUM Dialysis Centres. She has participated in different congresses, courses and updates on care and improvement of vascular accesses and she is proud to have participated in the EffPAc- clinical trial. She wants to continue her career in vascular access. Publications: • Ultrasound-guided left internal jugular vein cannulation: Advantages of a lateral oblique axis approach. Moreno-Sanchez T, Moreno-Ramírez M. Hemodialysis International 2020 AUG 27. doi 10.1111/hdi.12858. • Efficacy of Paclitaxel Balloon for Hemodialysis Stenosis Fistulae After One Year Compared to High-Pressure Balloons: A Controlled, Multicenter, Randomized Trial. Moreno-Sánchez T, Moreno-Ramírez M, et al. Cardiovasc Intervent Radiol. 2020 Mar;43(3):382-390. doi: 10.1007/s00270-019-02372-w. Most representative scientific exhibits: • GEMAV Congress. 20Nov: 2nd prize for the best communication: Permeabilidad secundaria y estrógenos: ¿Se relacionan con la supervivencia del acceso vascular? • CIRSE Congress. 20Sept. Efficacy of Paclitaxel Balloon for Hemodialysis Stenosis Fistulae After One Year Compared to High-Pressure Balloons. • SERVEI Congress. 19May: 1st prize for the best communication: ¿Es la edad del paciente en HD un factor de riesgo en la re-estenosis tars angioplastia de la FAV? • CIRSE Congress. 18Sept. A prospective, multicenter, randomized, double blind, controlled study of coated drug balloon versus high pressure balloon (HPB) for stenosis in fistulae for hemodialysis (preliminary results).